Biocryst Pharmaceuticals (BCRX) FCF Margin Growth (3y) (2013 - 2026)
Biocryst Pharmaceuticals (BCRX) FCF Margin Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 253.00 |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -1,444.00 |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -1,941.00 |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 4,671.00 |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 1,067.00 |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -42,016.00 |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 895.00 |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 830.00 |
| 10 | Biocryst Pharmaceuticals | 2.02 Bn | 1.78 Bn | 151.04 Mn | 2,942.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2,942.00 |
| Dec 31, 2025 | 4.14 Mn |
| Sep 30, 2025 | 6,876.00 |
| Jun 30, 2025 | 6,736.00 |
| Mar 31, 2025 | 13,775.00 |
| Dec 31, 2024 | 6,670.00 |
| Sep 30, 2024 | 6,433.00 |
| Jun 30, 2024 | 5,145.00 |
| Mar 31, 2024 | 26,251.00 |
| Dec 31, 2023 | 105,508.00 |
| Sep 30, 2023 | 60,567.00 |
| Jun 30, 2023 | 106,029.00 |
| Mar 31, 2023 | 41,580.00 |
| Dec 31, 2022 | -414.00 |
| Sep 30, 2022 | 151,867.00 |
| Jun 30, 2022 | 165,534.00 |
| Mar 31, 2022 | 30,353.00 |
| Dec 31, 2021 | 81,152.00 |
| Sep 30, 2021 | 235,450.00 |
| Jun 30, 2021 | 6,021.00 |